Regenerative Medical Technology Group Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Regenerative Medical Technology Group Inc. stock issued during period, value, other for the quarter ending 2021-12-31 was $0.00.
- Regenerative Medical Technology Group Inc. stock issued during period, value, other for the quarter ending 2021-09-30 was $0.00.
- Regenerative Medical Technology Group Inc. stock issued during period, value, other for the quarter ending 2021-06-30 was $213.11K, a 463.32% increase year-over-year.
- Regenerative Medical Technology Group Inc. stock issued during period, value, other for the quarter ending 2021-03-31 was $359.13K, a 178.47% increase year-over-year.
- Regenerative Medical Technology Group Inc. stock issued during period, value, other for fiscal 2021 was $213.11K, a 27.77% increase from fiscal 2020.
- Regenerative Medical Technology Group Inc. stock issued during period, value, other for fiscal 2020 was $166.79K.
- Regenerative Medical Technology Group Inc. stock issued during period, value, other for fiscal 2018 was $1.82K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-05 | $213.11K 10-K · filed 2022-05-05 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-12-22 | $572.24K derived: sum of 4 quarters · filed 2022-05-19 |
| 2021-06-30 | $213.11K 10-Q · filed 2021-08-13 | $572.24K derived: sum of 4 quarters · filed 2022-05-19 |
| 2021-03-31 | $359.13K 10-Q · filed 2022-05-19 | $396.96K derived: sum of 4 quarters · filed 2022-05-19 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-13 | $166.79K 10-K · filed 2021-04-13 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-24 | |
| 2020-06-30 | $37.83K 10-Q · filed 2021-02-08 | |
| 2020-03-31 | $128.96K derived: 10-K 12 month − 3 quarters · filed 2021-04-13 | |
| 2018-12-31 | $1.82K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-09 | $1.82K 10-K · filed 2020-12-09 |